203 related articles for article (PubMed ID: 9389549)
1. Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.
Sourla A; Luo S; Labrie C; Bélanger A; Labrie F
Endocrinology; 1997 Dec; 138(12):5605-17. PubMed ID: 9389549
[TBL] [Abstract][Full Text] [Related]
2. Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice.
Luo S; Sourla A; Labrie C; Gauthier S; Merand Y; Belanger A; Labrie F
Endocrinology; 1998 May; 139(5):2645-56. PubMed ID: 9564882
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice.
Luo S; Martel C; Sourla A; Gauthier S; Mérand Y; Belanger A; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(3):381-91. PubMed ID: 9359486
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice.
Couillard S; Gutman M; Labrie C; Bélanger A; Candas B; Labrie F
Cancer Res; 1998 Jan; 58(1):60-4. PubMed ID: 9426058
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
Martel C; Labrie C; Bélanger A; Gauthier S; Mérand Y; Li X; Provencher L; Candas B; Labrie F
Endocrinology; 1998 May; 139(5):2486-92. PubMed ID: 9564862
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Luo S; Stojanovic M; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
Gutman M; Couillard S; Roy J; Labrie F; Candas B; Labrie C
Int J Cancer; 2002 May; 99(2):273-8. PubMed ID: 11979444
[TBL] [Abstract][Full Text] [Related]
8. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
Labrie F; Labrie C; Bélanger A; Simard J; Gauthier S; Luu-The V; Mérand Y; Giguere V; Candas B; Luo S; Martel C; Singh SM; Fournier M; Coquet A; Richard V; Charbonneau R; Charpenet G; Tremblay A; Tremblay G; Cusan L; Veilleux R
J Steroid Biochem Mol Biol; 1999; 69(1-6):51-84. PubMed ID: 10418981
[TBL] [Abstract][Full Text] [Related]
9. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland.
Sourla A; Martel C; Labrie C; Labrie F
Endocrinology; 1998 Feb; 139(2):753-64. PubMed ID: 9449650
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Li S; Lévesque C; Geng CS; Yan X; Labrie F
Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
Simard J; Sanchez R; Poirier D; Gauthier S; Singh SM; Merand Y; Belanger A; Labrie C; Labrie F
Cancer Res; 1997 Aug; 57(16):3494-7. PubMed ID: 9270018
[TBL] [Abstract][Full Text] [Related]
12. EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium.
Labrie F; Labrie C; Bélanger A; Simard J; Giguère V; Tremblay A; Tremblay G
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):213-25. PubMed ID: 11850228
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
Luo S; Sourla A; Labrie C; Bélanger A; Labrie F
Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961
[TBL] [Abstract][Full Text] [Related]
14. Histologic changes in ovary, uterus, vagina, and mammary gland of mature beagle dogs treated with the SERM idoxifene.
Rehm S; Solleveld HA; Portelli ST; Wier PJ
Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):225-32. PubMed ID: 17570126
[TBL] [Abstract][Full Text] [Related]
15. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
Couillard S; Labrie C; Bélanger A; Candas B; Pouliot F; Labrie F
J Natl Cancer Inst; 1998 May; 90(10):772-8. PubMed ID: 9605648
[TBL] [Abstract][Full Text] [Related]
16. Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat.
Sourla A; Flamand M; Bélanger A; Labrie F
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):137-49. PubMed ID: 9719448
[TBL] [Abstract][Full Text] [Related]
17. Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats.
Trivedi RN; Chauhan SC; Dwivedi A; Kamboj VP; Singh MM
Contraception; 1995 Jun; 51(6):367-79. PubMed ID: 7554978
[TBL] [Abstract][Full Text] [Related]
18. Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).
Luo S; Labrie C; Bélanger A; Candas B; Labrie F
Breast Cancer Res Treat; 1998 May; 49(1):1-11. PubMed ID: 9694606
[TBL] [Abstract][Full Text] [Related]
19. Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists.
Skarda J; Köhlerová E
J Vet Med A Physiol Pathol Clin Med; 2006 Apr; 53(3):145-53. PubMed ID: 16533331
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.
Martel C; Picard S; Richard V; Bélanger A; Labrie C; Labrie F
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):45-56. PubMed ID: 11074355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]